Equities

Doximity Inc

Doximity Inc

Actions
Health CareHealth Care Providers
  • Price (USD)40.63
  • Today's Change0.57 / 1.42%
  • Shares traded1.31m
  • 1 Year change+99.17%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 00:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments763841798
Total Receivables, Net10711281
Total Inventory------
Prepaid expenses431719
Other current assets, total--5.125.51
Total current assets913975904
Property, plant & equipment, net25259.58
Goodwill, net686819
Intangibles, net27327.91
Long term investments------
Note receivable - long term------
Other long term assets1.461.652.26
Total assets1,0791,137991
LIABILITIES
Accounts payable2.251.270.46
Accrued expenses262226
Notes payable/short-term debt000
Current portion long-term debt/capital leases------
Other current liabilities, total11911785
Total current liabilities147140111
Total long term debt000
Total debt000
Deferred income tax------
Minority interest------
Other liabilities, total31311.48
Total liabilities178171113
SHAREHOLDERS EQUITY
Common stock0.190.190.19
Additional paid-in capital824762703
Retained earnings (accumulated deficit)80218191
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(2.66)(14)(15)
Total equity901966879
Total liabilities & shareholders' equity1,0791,137991
Total common shares outstanding187194192
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.